That first video could refer to CYDY's MAB, but some ambiguity appears.
Other videos show Dr. Bhatt reviewing data from the Amarin Reduce-It trial of Vascepa. I have numerous links to various data sources on Vascepa that may be obtained by clicking on north40000 above under "My stocks".
Why are those links pertinent? Patients afflicted with Corona Virus often die from CVDs--various cardiovascular events like heart attacks, strokes. Vascepa reduces the risk of death from CVDs. Resolvins have been referred to in literature as potential mitigators of cytokine effects of the current Corona viral affliction.